Ads
related to: SARS-CoV-2Highly-Validated Antibodies for Western Blot, ICC/IF, IHC, Flow Cytometry, ChIP, ELISA. Quality Guaranteed.
Human/Mouse/Rat/Humanized/Chimeric Recombinant Antibodies for Research Use. Free Inquiry! Applicable for WB, Cyt, CyTOF, ELISA, FC, FuncS, ICC, IHC, Inhib, IP, Neut, RIA, et al.
Search results
Jul 11, 2024 · But SARS-CoV-2, the coronavirus that causes COVID, is still mutating, raising concerns about a potential wave of infections this summer. In April, a group of new virus strains known as the FLiRT variants (based on the technical names of their two mutations) began to spread, followed in June by a variant known as LB.1.
Jun 28, 2024 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, causes a spectrum of symptoms ranging from mild upper to severe lower respiratory tract infections.
Jul 15, 2024 · Existing research in the U.S. indicates a large increase in SARS-CoV-2 antibody seroprevalence from the pre-Omicron to Omicron era across all age groups; it was estimated that by the third quarter of 2022, approximately two-thirds of individuals aged 16 years and older had been infected with SARS-CoV-2 with approximately half of individuals having hybrid immunity.
Jul 18, 2024 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to adapt to the herd immunity background and evolve into numerous sub-variants.
Jul 2, 2024 · The team identified new host factors that interact with the receptor binding domain of the SARS-CoV-2 spike protein to promote viral entry. This finding offers valuable mechanistic insights and ...
Jul 2, 2024 · SARS-CoV-2 has previously been documented in bone tissues in 2 reported cases, neither of which were in the skull . Here, we present results of SARS-CoV-2 analyses from 22 deceased persons with PCR-confirmed COVID-19 and detail our experience of managing the occupational hazards associated with COVID-19 autopsies.
Jul 17, 2024 · The etiologic agent of the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ().SARS-CoV-2 binds the cellular receptor, angiotensin-converting enzyme 2 (ACE2), through its envelope glycoprotein spike (S), which subsequently enables entry into the host cell by promoting fusion of viral and cellular membranes (2–10).
